HepCBC Mission Statement

HepCBC is a non-profit organization run by and for people infected and affected by hepatitis C. Our mission is to provide education, prevention and support to those living with HCV.

Hot Off The Press!

The Week in Review: March 17, 2017 – March 24, 2017

Friday, March 24, 2017 News Recap Well, if you've been up to our site and seen the daily news posts you will have seen that new drug access policies have now come into effect in BC and Quebec, as well as Ontario. It looks like the slate is the same for these 3 provinces, and we are listing what's available in BC so you can make sense of it.  For more information on the expanded access criteria in Quebec see here, and in particular the note from CD. ...

Selkirk College Student Nurses Bring HEPCBC and ANKORS to Hepatitis C Info Event

HepCBC was thrilled to get an invitation to a Selkirk College student nurse-initiated seminar in Castlegar, BC March 20, 2017. Robin Tomlin, HepCBC Board Member from nearby Robson, coordinated with the students, Janelle Jaworenko and Katrina Verigin, and their instructor Tammy McLean. Robin joined our President, Rosemary Plummer, RN, and Volunteer Cheryl Reitz for the day. Starting at 8 am sharp, we presented "Hepatitis C 101," bringing in all the latest

British Columbia lists EPCLUSA™ on public drug plan to treat all six genotypes of chronic hepatitis C infection

-- British Columbia Also Broadens Access for Patients with Less Advanced Disease Who Have Other Health Conditions -- MISSISSAUGA, ON, March 21, 2017 /CNW/ - Gilead Sciences Canada, Inc. (Gilead Canada) today announced, effective March 21, 2017, British Columbia will provide public access to EPCLUSA™ (sofosbuvir/velpatasvir) tablets, the first once-daily, pan-genotypic single tablet regimen for the treatment of adults with genotype 1-6 chronic hepatitis C ...

ZEPATIER® now covered in Quebec for the treatment of chronic hepatitis C

KIRKLAND, QC, March 21, 2017 /CNW Telbec/ - Merck Canada Inc. today announced that ZEPATIER® (elbasvir/grazoprevir) will be listed among the drugs covered by Quebec's health insurance board, the Régie de l'assurance maladie du Québec (RAMQ), as of March 22. Quebec joins other jurisdictions that have approved the product for reimbursement under their public healthcare plans for chronic hepatitis C patients presenting with recognized criteria. Zepatier is i

Canada needs Hepatitis C testing strategy, says N.W.T. MP

Michael McLeod wants Health Canada to step up efforts to educate people about Hep C testing. "This is an issue that's curable... I'm going to stay on this issue and continue to push the fact that we need a strategy," says Liberal N.W.T. MP Michael McLeod. The MP for the Northwest Territories is calling on the federal government to develop a national Hepatitis C education strategy. McLeod said the Northwest Territories has one of the highest rates of He